Last update :
01/04/2025
Anticancer drug   Pertuzumab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Perjeta Argentina, Australia, Belgium, Brazil, Canada, Chile, Ecuador, Finland, France, Germany, Great Britain, Hungary, Iceland, Ireland, Italy, Japan, Luxembourg, Mexico, Norway, Peru, Romania, Slovenia, Spain, Sweden, Switzerland, Tunisia, Turkey, United States of America
Stability in solutions   injection   Stability in solutions : Pertuzumab     
Container Solvent Concentration Temperature Storage Duration of stability References
partially used vials None 30 mg/ml 2-6°C Light
42 Day
4892
Level of evidence A+

Polyvinyl chloride Sodium chloride 0,9% 1.6 & 3 mg/ml 2-8°C Protect from light
30 Day
4686
Manufacturer's stability data

Polyvinyl chloride Sodium chloride 0,9% 1.6 & 3 mg/ml 30°C Protect from light
24 Hour
4686
Manufacturer's stability data

Polyvinyl chloride Sodium chloride 0,9% 3 mg/ml 30°C
24 Hour
3366
Level of evidence B+

Polyvinyl chloride Sodium chloride 0,9% 3 mg/ml 5°C Not specified
24 Hour
3366
Level of evidence B+

Polyolefine Sodium chloride 0,9% 1,59 mg/ml 17-23°C Light
28 Day
4892
Level of evidence A+

Polyolefine Sodium chloride 0,9% 1,59 mg/ml 2-6°C Light
28 Day
4892
Level of evidence A+

Polyolefine Sodium chloride 0,9% 1.6 & 3 mg/ml 2-8°C Protect from light
30 Day
4686
Manufacturer's stability data

Polyolefine Sodium chloride 0,9% 1.6 & 3 mg/ml 30°C Protect from light
24 Hour
4686
Manufacturer's stability data

Polyolefine Sodium chloride 0,9% 3 mg/ml 30°C Light
24 Hour
3366
Level of evidence B+

Polyolefine Sodium chloride 0,9% 3 mg/ml 5°C Not specified
24 Hour
3366
Level of evidence B+


  Mentions Légales